InvestorsObserver is giving Immunovant Inc (IMVT) an Analyst Rating Rank of 60, meaning IMVT is ranked higher by analysts than 60% of stocks. The average price target for IMVT is $27.875 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating IMVT a Strong Buy today. Find out what this means to you and get the rest of the rankings on IMVT!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Immunovant Inc Stock Today?
Immunovant Inc (IMVT) stock is trading at $8.47 as of 10:09 AM on Monday, Aug 30, a gain of $0.07, or 0.83% from the previous closing price of $8.40. The stock has traded between $8.44 and $8.91 so far today. Volume today is low. So far 179,225 shares have traded compared to average volume of 1,534,309 shares.
Click Here to get the full Stock Report for Immunovant Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
